chrisvoncsefalvay/vaers-outcomes huggingface dataset:
50 yr old female felt dizzy and lethargic after receiving first covid 19 vaccine. pt started feeling symptoms immediately aster entering the observation area. pt was wheeled to medical room via wc and was assessed. pt vs were taken and bp was elevated at 157/92, pt hr was 88, resp 18, so2 98% ra and ls clear bil. pt wanted to lie down on stretcher flat and rest. pt states she had a similar experience after giving platelets and had to be t/p to emergency room and was d/c after receiving iv fluids and a sandwich. pt was monitored for her bp every 10mins and was given water to drink due to pt denying n/v. pt bp remained stable but elevated around 145 systolic. pt could shake feeling dizzy and requested to be t/p to emergency room. 911 was notified and fire dept was enroute to t/p pt to hospital upon pt request. pt received a 500ml of 0.95 ns running kvo in int establishments in rt hand via 20g catheter. pt bel was 135 mg/dl and pt vs were taken and final set was 152/102, hr 86, resp 18, spo2 99% ra and ls were clear bil. pt was t/f to stretcher and report was given to crew for transfer of care. pt was t/p to er w/o further incident.
Two days after injection noted swelling to lips not both at the same time but goes back and forth between the two, then two days later noted fever blister on bottom lip and tongue felt sensitive. These sx have continued off and on.
Pt received Influenza vaccine on 9/30/09 @ about 10 am. RTC on 10/1/09 at 17:00 with erythematous edematous skin rxn  about 6x4cm in size at injection site. Site tender to palpitation. No other s/s or rxn. VSS. No Hx of  previous rxn or hx allergy to eggs Tx TYLENOL, BENADRYL, cold compress.  Reinjected 10/05/09 by Dr pt seen. 10/5 mild bruise present, otherwise no sx. Pt as sx were commonly.
no adverse event; administered an impropery stored dose of PEDVAX HIB; This spontaneous report was received from a nurse regarding a patient of unknown age and gender. Patient's pertinent medical history, concurrent conditions, past drugs, allergies and concomitant therapies were not reported. On 09-APR-2020, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (strength, dose and route were not reported) (lot number S023645 and expiration date 10-MAR-2022) for prophylaxis (product storage error). The temperature excursion was noted with a temperature of 51.5 Fahrenheit (F) for 45 minutes. There was no previous temperature excursion. No adverse effects were reported. The call was because of digital data logger. No product quality complaint was reported.  This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-2005USA002553:
Red and swollen down to elbow. Headaches that would come and go on their own. Intestinel problems.
8 hours after shot severe headache that started in back of neck, freezing cold, shaking and shivering uncontrollably. Back ache. Shakes and shivers lasted 4 hours. Headache and back ache lasted 48 hours. Severe fatigue for first 24 hours, last 24 hours moderate fatigue. After 48 hours, I was back to 100% health. I took aspirin to begin with for the headache, then switched to ibuprofen when aspirin didn?t work for headache.  Ibuprofen helped back ache immensely. Also, when pharmacist gave me the 2nd shot when I got home and changed clothes I realized I had bled a lot. Blood had oozed out from the bandage and down to my elbow. Arm sore for 2 days, and still swollen on 4th day a bit larger than golf ball size.
2 days after vaccination, developed pain, redness and swelling on left arm. Also concern with some loss of balance.
> 1 dozen red papules with some vesicles on the trunk (1 or the trunk is slightly crusted over) and few vesicles on face.
Symptoms started 2 days after immunization that was given on 01/12/2005: fever, vomiting, diarrhea, crank, and crying. No rash, cold symptoms, occassional cough and no sick family members. Seen 01/19/05, instructed to continue Tylenol or Motrin and pedialyte or gatorade.
First, the shot was given incorrectly, which caused some of the adverse affect.   I asked for the right arm as she was preparing for the left, and the provider ended up injecting me high on the shoulder, and I felt an unusual pressure inside my arm, rather than the usual zing of the needle.   My first symptom was the onset of excrusiating pain in my right shoulder, which I believe is because of the bad placement.   This continued through the first night, but gradually improved the next morning (now 85% relieved?) I also had the expected mild flue type symptoms the next day, but was able to do a few things.   By the middle of this second day, my lower back started hurting - a lot.   Similar to the shoulder in that it was unexpected and not in line with 'normal' Shingrix symptoms.   I couldn't stand up straight or do much of anything because it hurt so much.   I spent the rest of the day laying down and trying not to make it worse. The next day (#3 - 6/28) it was still there, so I did the same thing in the morning - just tried not to move much.   In the afternoon I thought better of that and looked up some physical therapy exercises for this type of pain and tried them, I walked (slowly) on our treadmill and used a heating pad and ice.   Either it worked or the same thing happened as with my shoulder and it just started to get better.   I was more comfortable that night and decided to go to work today (6/29). The lower back pain is not yet gone - it's about half better.   I can walk around without tears, but I'm not completely upright and it is physically stressful (it makes me sweat).   I tried to take it easy, though my job is not all at a desk.   I made an appointment late in the day to go discuss this at the same clinic, and I'm planning an evening of ice and rest.   My blood pressure was pretty high at the Dr. office. In our discussion we pretty much agree on the cause of the arm pain, though they will be looking into it further.  But why the lower back?   This doesn't seem to add up to anything related to the bad shot or Shingrix that we find online.    The mild flue symptoms have not occured today - that's over - and I have nothing happening besides the backach and remnant of the shoulder pain.   How could it move from one place to the other?   I haven't had any other back stress or occurance to cause this pain and it is very coincidental with the other issues this week.   So are they related?  My first Shingrix shot was 4/5/2023, at the same clinic.  Given correctly and only a few mild flu-like symptoms.   No problem.
fever 101, high fever; arm is hurting; sick to stomach; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 101, high fever), PAIN IN EXTREMITY (arm is hurting) and ABDOMINAL DISCOMFORT (sick to stomach) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046AZ1A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products were not provided.   On 28-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced PYREXIA (fever 101, high fever), PAIN IN EXTREMITY (arm is hurting) and ABDOMINAL DISCOMFORT (sick to stomach). At the time of the report, PYREXIA (fever 101, high fever), PAIN IN EXTREMITY (arm is hurting) and ABDOMINAL DISCOMFORT (sick to stomach) outcome was unknown.  Treatment products were not provided.
Initial report received 23 February 2009 from a health care professional. A 4-year-old female patient had received a third dose intramuscular left deltoid injection of FLUZONE 2008-2009, lot number U2809AA on 04 December 2008 at 12:15 hours, and within 10 minutes, the patient experienced a syncopal episode where she became pale, limp and unresponsive with bradycardia and a low respiratory rate. The patient remained unresponsive until EMS arrived at the physician's office. The patient was stimulated with sternal rub and oxygen by mask and taken to the emergency room. She was admitted overnight for observation and released the next day. The patient had no past medical history and had not been taking any concomitant medications. The patient recovered from the event. This patient has two brothers who each experienced a syncopal event post vaccination with FLUZONE which have been captured in case numbers 2008-03955 and 2009-00670. The reporter for this case is the same as for case numbers 2008-03955 and 2009-00670. Documents held by sender: None
test covid + 8/8 despite covid vaccinated on 1/4/2021 and 1/25/2021
received the first and second dose / 2-3 years ago / has shingles / 2 weeks ago; shingles; This case was reported by a consumer and described the occurrence of vaccination failure in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (before receiving shingrix). Previously administered products included Shingrix with an associated reaction of herpes zoster (refer case US2020019124).   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. In October 2020, more than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. Rechallenge with Shingrix was positive. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovering/resolving.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient received the first and second dose of the Shingrix vaccine about 2 to 3 years before reporting. The reporter stated she had shingles on the left side about 2 weeks before reporting and was seen at the urgent care.  The patient was feeling better and it had almost cleared. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020019124:same reporter
Swollen and blurred vision, itchy eyes with drainage. High fever and chills and difficulty breathing.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. Information regarding patients' medical history, current conditions and concomitant medications were not reported. On unknown dates, the patients received improperly stored ROTATEQ (lot # M04386, expiry date: 18-JUN-2018) for prophylaxis. Nurse reported that the vaccine underwent temperature excursion at 0-1 degree Celsius for 21 minutes. There were no previous temperature excursion. Data logger was involved. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1708USA005422:
I experienced flu symptoms, headaches, muscle aches, fever, nausea and swollen lymph nodes. I also had severe nerve pain on the right side of my body, it felt like it was on fire.
Acute pain, rear left shoulder.  Near total paralysis of left arm.  Numbness, tingling, weakness in left arm/hand.  Flu-like malaise that came and went.
GARDISAL 1ST SHOT-Sharp stomach pains and extremely nauseous. Lasted 12 hrs. Then dreamlike black out for 30 seconds 8:00 PM 24 hrs. AFTER receiving vaccine
FEELING ACHY; flu like symptoms; FEELS TIRED AND WORN OUT; LOW GRADE FEVER; JOINTS SORE AND ACHY; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (FEELING ACHY), INFLUENZA LIKE ILLNESS (flu like symptoms), FATIGUE (FEELS TIRED AND WORN OUT), PYREXIA (LOW GRADE FEVER) and ARTHRALGIA (JOINTS SORE AND ACHY) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced PAIN (FEELING ACHY), INFLUENZA LIKE ILLNESS (flu like symptoms), FATIGUE (FEELS TIRED AND WORN OUT), PYREXIA (LOW GRADE FEVER) and ARTHRALGIA (JOINTS SORE AND ACHY). At the time of the report, PAIN (FEELING ACHY), INFLUENZA LIKE ILLNESS (flu like symptoms), FATIGUE (FEELS TIRED AND WORN OUT), PYREXIA (LOW GRADE FEVER) and ARTHRALGIA (JOINTS SORE AND ACHY) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: low (Low) LOW GRADE FEVER.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
This is a spontaneous report from a contactable consumer reported for patient (mother). A 57-year-old female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# SC3180), at age 57, via an unspecified route of administration, left arm, on Aug 4, 2021, 17:45, single dose, for COVID-19 immunisation. The patient's medical history reported as none. The concomitant medications not reported. On Aug 4, 2021 at 22:00, patient experienced leg pain, back pain and body aches all over. On Aug 5, 2021 at 01:00, patient experienced chest pain. The caller stated patient was taken to the emergency room at 2:00 am on Thursday, Aug 5, 2021 because of chest pain. The caller stated prior to receiving the vaccine, her mother did not have any of these symptoms and did not have chest pain. The caller also reported her mother improving a little bit at home with pain killers. She was instructed by the emergency room doctor to follow up with her primary care provider. Her mother treated and released from the emergency room; and that day her mother's lower back pain was nothing like she had previous week. The back pain was part of her body aches. Caller stated her mother got the vaccine, at her recommendation. Now that she got the first dose, her mother said, she will not be getting the second dose of vaccine. They ran lab tests at the ER. Everything came back okay. The patient underwent lab tests and procedures, which included a blood test (came back okay on an unspecified date in Aug 2021); and a chest X-ray (came back okay on an unspecified date in Aug 2021). The outcome of the events reported: resolving.
On the same day, soreness and hardening of injected area. Over the night, headache, heat sensation, thirst, heaviness of whole body, nightmare, night sweat, bloated in stomach, insomnia occurred. Next day, severe fatigue and rested all day. Two days later, almost no symptoms. Three days later, nausea, mild diarrhea, lightheadedness, and depressed mood occurred.
Swollen lymph-nodes under vaccinated arm . Size of a vase ball . Soft to the touch not very painful
chills/ shivers; subjective fever; This case was reported by a nurse via sales rep and described the occurrence of chills in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced chills and feeling hot. On an unknown date, the outcome of the chills and feeling hot were unknown.   It was unknown if the reporter considered the chills and feeling hot to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced chills, shivers, subjective fever and required bed rest for approximately 1 week. The reporter agreed to follow up.
Patient did not have any adverse event at the pharmacy, this report is to put in that patient birthday was the day of vaccine and he turned 12, so he should've received the adult vaccine. Pt's father verbally confirmed and saw the consent form written age of 11 years old.
on the second Shot,  the area has about a 1 and  a half  inch , very dark bruise after a few days.    Also, arm seems weak a week later. First shot had no issues.
Numb lips; Random Itching all over her body; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (Numb lips) and PRURITUS (Random Itching all over her body) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to antibiotic (Various.) and Drug allergy (Benadryl). Concomitant products included LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 19-Mar-2021, the patient experienced HYPOAESTHESIA ORAL (Numb lips) and PRURITUS (Random Itching all over her body). The patient was treated with FAMOTIDINE (PEPCID AC) at an unspecified dose and frequency. On 21-Mar-2021, HYPOAESTHESIA ORAL (Numb lips) and PRURITUS (Random Itching all over her body) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment drugs were reported
This spontaneous case was reported by a consumer and describes the occurrence of decreased appetite (loss her appetite), pain (all over body pain) and fatigue in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The patient's past medical history included no adverse event. Concomitant products included tramadol and gabapentin for an unknown indication. On Jan 8, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Jan 8, 2021, patient experienced decreased appetite (loss her appetite), pain (all over body pain) and fatigue. On Jan 12, 2021, decreased appetite (loss her appetite), pain (all over body pain) and fatigue resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Other concomitant medications included unspecified blood pressure medication, blood thinner medication and cholesterol medication. Treatment medication included Bismuth subsalicylate.This case linked to MOD-2021-006211 (patient link). Reporter did not allow further contact. Sender's comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Little Aiky; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 01-Dec-2020.  This case involves a patient of unknown demographics who felt little aiky (pain), while the patient received Influenza vaccine.  The patient's medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.  On 30-Nov-2020, the patients received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On 01-Dec-2020, the patient felt little aiky (pain) after receiving Influenza vaccine.   The patient received Ibuprofen as corrective treatment for the event.  Outcome of the event was recovered, at the time of reporting.  There will be no information available on the batch number for this case.
This case was reported by a nurse via call center representative and described the occurrence of injection site pain in a 47-year-old male patient who received TWINRIX adult (batch number Z75Y2, expiry date unknown) for prophylaxis. Concomitant products included TWINRIX adult. On 9th January 2018, the patient received the 2nd dose of TWINRIX adult 1 ml. On 10th January 2018, 1 days after receiving TWINRIX adult, the patient experienced injection site pain (serious criteria disability), fatigue (serious criteria disability), nausea (serious criteria disability), headache (serious criteria disability) and diarrhea (serious criteria disability). On an unknown date, the outcome of the injection site pain, fatigue, nausea, headache and diarrhea were recovered/resolved. The reporter considered the injection site pain, fatigue, nausea, headache and diarrhea to be related to TWINRIX adult. Additional details were provided as follows: The patient received TWINRIX 2nd dose on the left deltoid. The next day he experienced soreness at injection site, headache, fatigue, nausea and diarrhea. The healthcare professional described the patient's symptoms after the 2nd dose as a general systemic reaction. The registered nurse made note that the patient was a very muscular man. The reporter did not have the expiry date of the lot number. The reported TWINRIX adult batch number (SKBZ75Y2) did not exist and was updated to Z75Y2 as per sales database. For tolerance to next dose, refer case US2018GSK113363.
bleed heavily with large blood clots; bleed heavily with large blood clots; chest pains; headache; hives on my neck; very sick; 2min after receiving, my throat started burning but never closed; numbness; rib pain; extremely fatigued; I recently am having some weird vision things happening; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 39-years-old female patient (patient was not pregnant at the time of vaccination) received an unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 01Jul2021 at 15:00 pm (age at the vaccination was 39 years) as dose number unknown, single for COVID-19 immunization. The patient's medical history included Ehlers Danlos. The patient did not have any known allergies. Concomitant medication the patient received within two weeks of vaccination included Amphetamine aspartate, amphetamine sulfate, dexamphetamine saccharate, dexamphetamine sulfate (ADDERALL) taken for an unspecified indication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 01Jul2021, 2 mins after receiving the vaccine, the patient's throat started burning but never closed and she took antihistamines and went to work. 48 hours later a headache started and hives on her neck, a few hours later she became very sick. The next morning she woke up to hives all over her legs and chest pains she began to bleed heavily with large blood clots. A few days later she felt better but weeks have gone by and she was still getting hives, numbness, rib pain, she hemorrhaged for eight days and that started again yesterday. She was extremely fatigued and still had hives coming and going. She was recently having some weird vision things happening. Obviously she had an immediate allergic reaction to something but now the vaccine was not meshing well with her body and symptom. She did have ehlers danlos syndrome and she realized there was just no real studies for ED patients and the vaccine. She was just hoping to let someone know what was going on. The adverse event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient received treatment with EKG, epi pen, allergist appt, opt out of 2nd dose. The outcome of the events was not resolved.  Information on the lot/batch number has been requested.
Hive on chest, face, back. Partially resolved after admin of diphenhydramine 30 mg  po. Pain at injection site. Hospital EMS